Literature DB >> 21337360

Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry.

Bryan Lau1, Stephen R Cole, Stephen J Gange.   

Abstract

In the analysis of survival data, there are often competing events that preclude an event of interest from occurring. Regression analysis with competing risks is typically undertaken using a cause-specific proportional hazards model. However, modern alternative methods exist for the analysis of the subdistribution hazard with a corresponding subdistribution proportional hazards model. In this paper, we introduce a flexible parametric mixture model as a unifying method to obtain estimates of the cause-specific and subdistribution hazards and hazard-ratio functions. We describe how these estimates can be summarized over time to give a single number comparable to the hazard ratio that is obtained from a corresponding cause-specific or subdistribution proportional hazards model. An application to the Women's Interagency HIV Study is provided to investigate injection drug use and the time to either the initiation of effective antiretroviral therapy, or clinical disease progression as a competing event.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21337360      PMCID: PMC3069508          DOI: 10.1002/sim.4123

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

1.  Competing risks as a multi-state model.

Authors:  Per Kragh Andersen; Steen Z Abildstrom; Susanne Rosthøj
Journal:  Stat Methods Med Res       Date:  2002-04       Impact factor: 3.021

2.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

3.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

5.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

6.  Properties of proportional-hazards score tests under misspecified regression models.

Authors:  S W Lagakos; D A Schoenfeld
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

7.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

8.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

9.  Self-reported antiretroviral therapy in injection drug users.

Authors:  D D Celentano; D Vlahov; S Cohn; V M Shadle; O Obasanjo; R D Moore
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

10.  All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population.

Authors:  Olivia Keiser; Patrick Taffé; Marcel Zwahlen; Manuel Battegay; Enos Bernasconi; Rainer Weber; Martin Rickenbach
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

View more
  13 in total

Review 1.  Applying competing risks regression models: an overview.

Authors:  Bernhard Haller; Georg Schmidt; Kurt Ulm
Journal:  Lifetime Data Anal       Date:  2012-09-26       Impact factor: 1.588

Review 2.  Survival analysis in hematologic malignancies: recommendations for clinicians.

Authors:  Julio Delgado; Arturo Pereira; Neus Villamor; Armando López-Guillermo; Ciril Rozman
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

3.  Nonparametric Assessment of Differences Between Competing Risk Hazard Ratios: Application to Racial Differences in Pediatric Chronic Kidney Disease Progression.

Authors:  Derek K Ng; Daniel A Antiporta; Matthew B Matheson; Alvaro Muñoz
Journal:  Clin Epidemiol       Date:  2020-01-20       Impact factor: 4.790

4.  Bias Due to Confounders for the Exposure-Competing Risk Relationship.

Authors:  Catherine R Lesko; Bryan Lau
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

5.  Are all biases missing data problems?

Authors:  Chanelle J Howe; Lauren E Cain; Joseph W Hogan
Journal:  Curr Epidemiol Rep       Date:  2015-07-12

6.  Causal inference in the face of competing events.

Authors:  Jacqueline E Rudolph; Catherine R Lesko; Ashley I Naimi
Journal:  Curr Epidemiol Rep       Date:  2020-07-12

7.  Recursive Partitioning Method on Competing Risk Outcomes.

Authors:  Wei Xu; Jiahua Che; Qin Kong
Journal:  Cancer Inform       Date:  2016-07-26

8.  Smooth semi-nonparametric (SNP) estimation of the cumulative incidence function.

Authors:  Anh Nguyen Duc; Marcel Wolbers
Journal:  Stat Med       Date:  2017-05-23       Impact factor: 2.373

9.  Missingness in the Setting of Competing Risks: from missing values to missing potential outcomes.

Authors:  Bryan Lau; Catherine Lesko
Journal:  Curr Epidemiol Rep       Date:  2018-03-19

10.  Hospital-acquired Clostridium difficile infections: estimating all-cause mortality and length of stay.

Authors:  Eric T Lofgren; Stephen R Cole; David J Weber; Deverick J Anderson; Rebekah W Moehring
Journal:  Epidemiology       Date:  2014-07       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.